S3-Leitlinie Komplementrmedizin in der Behandlung von onkologischen PatientInnen Langversion Mai 2024, AWMF-Registernummer: 032/055OL Sato S, Namisaki T, Furukawa M, Saikawa S, Kawaratani H, Kaji K, Takaya H, Shimozato N, Sawada Y, Kitagawa K, Moriya K, Akahane T, Mitoro A, Hoki N, Ann T, Yoshiji H
You may still prescribe compounded GLP-1 drugs, but your prescription must clearly articulate a medically necessary significant difference from the commercially available drug product
Your healthcare provider will monitor your heart rate at your usual medical visits during semaglutide use
Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, Pan A, Zhang C, Jia J, Feng L, Kua EH, Wang YJ, Wang HF, Tan MS, Li JQ, Hou XH, Wan Y, Tan L, Mok V, Tan L, Dong Q, Touchon J, Gauthier S, Aisen PS, Vellas B
If your insurance does not cover Foundayo, self-pay options from LillyDirect offer a more accessible entry point than most prior GLP-1 treatments